| Triple-negative breast cancer: understanding Wnt signaling in drug resistance P Merikhian, MR Eisavand, L Farahmand Cancer cell international 21 (1), 419, 2021 | 47 | 2021 |
| Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling F Khodabakhsh, P Merikhian, MR Eisavand, L Farahmand Cancer Cell International 21 (1), 200, 2021 | 27 | 2021 |
| MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy A Hosseinzadeh, P Merikhian, N Naseri, MR Eisavand, L Farahmand Cancer Cell International 22 (1), 110, 2022 | 20 | 2022 |
| Cellular stress response to extremely low‐frequency electromagnetic fields (ELF‐EMF): An explanation for controversial effects of ELF‐EMF on apoptosis M Barati, B Darvishi, MA Javidi, A Mohammadian, SP Shariatpanahi, ... Cell Proliferation 54 (12), e13154, 2021 | 20 | 2021 |
| Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk K Barzaman, R Vafaei, M Samadi, MH Kazemi, A Hosseinzadeh, ... Cancer Cell International 22 (1), 259, 2022 | 14 | 2022 |
| Matrix stiffening and acquired resistance to chemotherapy: Concepts and clinical significance B Darvishi, MR Eisavand, K Majidzadeh-A, L Farahmand British Journal of Cancer 126 (9), 1253-1263, 2022 | 12 | 2022 |
